Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6526
Source ID: NCT00282971
Associated Drug: Inhaled Insulin (Exubera)
Title: A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
Acronym:
Status: TERMINATED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00282971/results
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: Inhaled Insulin (Exubera)|OTHER: Standard of Care
Outcome Measures: Primary: Percentage Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24, \[(week 24 value - baseline value)/baseline value\]\*100%, 4, 12 and 24 weeks | Secondary: Percentage of Participants Achieving Glycemic Control by Visit, 2 definitions of good glycemic control were used: an HbA1c result of ≤6.5% or ≤7.0%, 4, 12 and 24 weeks|Change From Baseline in FEV1 at Week 24 LOCF, 24 weeks
Sponsor/Collaborators: Sponsor: Pfizer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 354
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2006-03-06
Completion Date: 2008-02-19
Results First Posted: 2009-08-26
Last Update Posted: 2019-04-02
Locations: Gain Medical Center, Coquitlam, British Columbia, V3K 3P4, Canada|Misericordia Health Centre, Winnipeg, Manitoba, R3C 1A2, Canada|Maritime Research Center, Bathurst, New Brunswick, E2A 4X7, Canada|Office of Dr. Salim Sunderji, London, Ontario, N6P 1A9, Canada|Orillia Soldier's Memorial Hospital, Orillia, Ontario, L3V 2Z6, Canada|Douglas Tweel M.D. Professional Corporation, Charlottetown, Prince Edward Island, C1A 1L2, Canada|Laboratoire Sante Le Gaspesien Inc., Bonaventure, Quebec, G0C 1E0, Canada|Centre de santé et de services sociaux de Chicoutimi, Centre de médecine genique communataire, Chicoutimi, Quebec, G7H 5H6, Canada|Rhodin Recherche Clinique, Drummondville, Quebec, J2B 1H8, Canada|Q & T Research Outaouais Inc., Gatineau, Quebec, J8Y 6S9, Canada|Hopital Charles LeMoyne, Greenfield Park, Quebec, J4V2H1, Canada|Hopital Laval, Saint-Foy, Quebec, G1V 4G5, Canada|Centre Medical des Carrieres, St-Marc-des-Carrieres, Quebec, G0A 4B0, Canada|CIC Mauricie Inc., Trois-Rivières, Quebec, G8T 7A1, Canada|Hotel Dieu CHU, Clinique d´Endocrinologie, Maladie Metaboliques, Nutrition, Nantes, Cedex 01, F-44035, France|Groupe Hospitalier Sud/Service d'Endocrinologie, Amiens cedex 1, 80094, France|Private Practise, Armentieres, 59427, France|Service d'Endocrinologie-, Bondy Cedex, 93143, France|Hopital LA Cavale Blanche, Service de Diabetologie, Brest CEDEX, 29609, France|CHU Cote de Nacre, Service d'Endocrinologie, Cean Cedex, 14033, France|Private Practise, Chartres, 28000, France|Office of Antoine Lemaire, MD, Lille, 59000, France|Centre Hospitalier Bretagne Sud, Lorient Cedex, 56322, France|Hopital Lapeyronnie Sce des Maladies, Montpellier CEDEX 5, 34295, France|Hopital Bichat, Service d'Endocrinology, Paris Cedex 18, 75877, France|Hopital Saint Michel, Paris, 75015, France|Hopital Robert Debre, Reims, 51100, France|C.H. Sud, Diabetologie, Rennes, 35056, France|Centre Hospitalier Victor Provo, Roubaix, 59100, France|Hôpital Jeanne d'Arc - Dommartin les Toul, Toul Cedex, 54201, France|General Hospital of Athens "Laikon", 1st Propedeutic University Internal Medicine Clinic, Athens, 11527, Greece|"Hygeia" Diagnostic and Therapeutic Center of Athens, Diabetes Clinic, Athens, 151 23, Greece|"ATTIKON" University General Hospital, 2nd Propedeutic University Internal Medicine Clinic, Haidari, 124 62, Greece|Peripheral General Hospital of Nikaia "Ag. Panteleimon", Internal Medicine Department, Pireaus, 18454, Greece|University General Hospital of Thessaloniki "A.H.E.P.A." 1st Propedeutic University Internal Medicin, Thessaloniki, 546 36, Greece|Hospital Infante D. Pedro, Aveiro, 3814-096, Portugal|Hospitais da Universidade de Coimbra, Coimbra, 3000-075, Portugal|Associação Protectora dos Diabéticos de Portugal, Lisboa, 1250-203, Portugal|Serviço de Endocrinologia - Hospital de Egas Moniz, Lisboa, 1300, Portugal|Hospital Geral de Santo António, Porto, 4099-001, Portugal|Centro Hospitalar de Torres Vedras, Torres Vedras, 2560-324, Portugal|Hospital Clinico Universitario de Santiago, Santiago de Compostela, A Coruña, 15706, Spain|Hospital de Conxo, Santiago de Compostela, A Coruña, 15706, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33006, Spain|Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Mutua de Terrassa, Terrassa, Barcelona, 08221, Spain|Clinica Universitaria de Navarra, Pamplona, Navarra, 31008, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital de La Santa Creu I Sant Pau, Barcelona, 08025, Spain|Hospital General Universitario Valle de Hebron, Barcelona, 08035, Spain|Hospital Universitario Puerta de Hierro, Madrid, 28035, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital de Mostoles, Madrid, 28935, Spain|Complejo Hospitalario Carlos Haya Hospital Civil - Pabellon C, Malaga, 29009, Spain|Hospital Montecelo, Pontevedra, 36071, Spain|Hospital Universitario La Fe, Valencia, 46009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain|Sodersjukhuset, Stockholm, 118 83, Sweden|Karolinska US Huddinge, Stockholm, 141 86, Sweden|Ängelholms sjukhus, Ängelholm, 262 81, Sweden|Hacettepe University Medical School Department of Endocrinology, Anakara, Turkey|Istanbul University Istanbul Medical School, Department of Endocrinology, Istanbul, 34390, Turkey|Dokuz Eylul University Medical School, Department of Endocrinology, Izmir, 35340, Turkey
URL: https://clinicaltrials.gov/show/NCT00282971

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress